What Happens If Your Telehealth Provider Shuts Down Mid-Prescription
GLP-1 platforms have shut down, pivoted, and lost supply chains since 2023. How to assess platform stability risk, the signs of a platform in trouble, and the response protocol if shutdown happens.
Several GLP-1 telehealth platforms have shut down, pivoted, or changed their formularies since 2023. The FDA's compounding guidance proposal (comment period closed June 2026) adds regulatory risk to platforms built entirely on compounded supply. Here's how to assess platform stability and what to do if your provider shuts down.
Why GLP-1 platforms shut down
The causes cluster in a few categories: regulatory pressure (FDA Warning Letters, state board actions), supply chain issues (503B compounding restrictions), financial failure (VC-backed platforms burning cash), acquisition and rebranding, or quiet exit from the GLP-1 market when margins compress. None of these are rare outcomes in a market that's been growing as fast as compounded GLP-1 has.
Platforms whose formulary is entirely dependent on 503B compounded semaglutide or tirzepatide face the highest regulatory risk. If the FDA's proposed 503B exclusion is finalized, large-scale 503B compounding becomes unavailable. Platforms with brand-name prescribing capability, diverse formularies, or 503A (individual prescription) pharmacy relationships are more resilient to this specific risk.
Signs a platform may be in trouble
- Delayed shipping with no communication
- Customer service response times degrading
- Formulary changes without notice (switching from one compound to another)
- New medication supply requiring upfront multi-month payment
- Prescriber turnover — different providers on every visit
- FDA Warning Letter received (not necessarily fatal, but indicates scrutiny)
What to do if your platform shuts down
Shutdown response protocol
- Download all records immediately — account deletion may follow platform closure
- Get refills from your current supply before the platform confirms closure
- Contact a new platform — your records and current dose make transfer straightforward
- If you had insurance PA, contact your insurer — they may have records even if the platform doesn't
- File a complaint with your state insurance commissioner if you paid for medication that wasn't delivered
Verified telehealth providers
Established platform, diversified formulary including brand-name options.
Paid link Get started →Stable 503A compounding partnerships, consistent supply.
Paid link Get started →